Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$229,842
+$40,401 QoQ
Shares Held
905
+16.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#4,403
of 4,664 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Mar 31, 2026CallValue
$24,444
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Entelevest, LLC holds $1,470,236 across 4 Drug Manufacturers - General names. JNJ ranks #4 (15.6% of the industry book) .
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,842 | 905 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $24,444 | 100 | Call | Sole | 2026-05-05 | |
| 2026-03-31 | $189,441 | 775 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||